טוען...
A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia
Tumor‐induced osteomalacia (TIO) is a rare cause of impaired bone mineralization mediated by the osteocyte‐derived, phosphaturic hormone: fibroblast growth factor 23 (FGF23). The case is presented of a previously healthy 45‐year‐old man who developed fragility fractures at multiple sites (initially...
שמור ב:
| הוצא לאור ב: | JBMR Plus |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7872335/ https://ncbi.nlm.nih.gov/pubmed/33615107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10438 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|